Molecular diagnostics for Chagas disease: up to date and novel methodologies

Chagas disease is caused by the parasite Trypanosoma cruzi. It affects 7 million people, mainly in Latin America. Diagnosis is usually made serologically, but at some clinical scenarios serology cannot be used. Then, molecular detection is required for early detection of congenital transmission, tre...

ver descrição completa

Detalhes bibliográficos
Autores: Alonso Padilla, Julio, Gállego Culleré, M. (Montserrat), Schijman, Alejandro G., Gascón i Brustenga, Joaquim
Formato: artículo
Estado:Versión aceptada para publicación
Fecha de publicación:2017
País:España
Recursos:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/204332
Acesso em linha:https://hdl.handle.net/2445/204332
Access Level:acceso abierto
Palavra-chave:Genètica molecular
Diagnòstic
Malaltia de Chagas
Molecular genetics
Diagnosis
Chagas' disease
id ES_3e3755d6e3a5a1c92cd9bbe9797aab71
oai_identifier_str oai:diposit.ub.edu:2445/204332
network_acronym_str ES
network_name_str España
repository_id_str
spelling Molecular diagnostics for Chagas disease: up to date and novel methodologiesAlonso Padilla, JulioGállego Culleré, M. (Montserrat)Schijman, Alejandro G.Gascón i Brustenga, JoaquimGenètica molecularDiagnòsticMalaltia de ChagasMolecular geneticsDiagnosisChagas' diseaseChagas disease is caused by the parasite Trypanosoma cruzi. It affects 7 million people, mainly in Latin America. Diagnosis is usually made serologically, but at some clinical scenarios serology cannot be used. Then, molecular detection is required for early detection of congenital transmission, treatment response follow up, and diagnosis of immune-suppression reactivation. However, present tests are technically demanding and require well-equipped laboratories which make them unfeasible in low-resources endemic regions.Taylor & Francis2017info:eu-repo/semantics/articleinfo:eu-repo/semantics/acceptedVersionapplication/pdfhttps://hdl.handle.net/2445/204332Articles publicats en revistes (Biologia, Sanitat i Medi Ambient)reponame:Dipòsit Digital de la UBinstname:Universidad de BarcelonaInglésVersió postprint del document publicat a: https://doi.org/10.1080/14737159.2017.1338566Expert Review Of Molecular Diagnostics, 2017, vol. 17, num.7, p. 699-710https://doi.org/10.1080/14737159.2017.1338566(c) Taylor & Francis, 2017info:eu-repo/semantics/openAccessoai:diposit.ub.edu:2445/2043322026-05-27T06:46:51Z
dc.title.none.fl_str_mv Molecular diagnostics for Chagas disease: up to date and novel methodologies
title Molecular diagnostics for Chagas disease: up to date and novel methodologies
spellingShingle Molecular diagnostics for Chagas disease: up to date and novel methodologies
Alonso Padilla, Julio
Genètica molecular
Diagnòstic
Malaltia de Chagas
Molecular genetics
Diagnosis
Chagas' disease
title_short Molecular diagnostics for Chagas disease: up to date and novel methodologies
title_full Molecular diagnostics for Chagas disease: up to date and novel methodologies
title_fullStr Molecular diagnostics for Chagas disease: up to date and novel methodologies
title_full_unstemmed Molecular diagnostics for Chagas disease: up to date and novel methodologies
title_sort Molecular diagnostics for Chagas disease: up to date and novel methodologies
dc.creator.none.fl_str_mv Alonso Padilla, Julio
Gállego Culleré, M. (Montserrat)
Schijman, Alejandro G.
Gascón i Brustenga, Joaquim
author Alonso Padilla, Julio
author_facet Alonso Padilla, Julio
Gállego Culleré, M. (Montserrat)
Schijman, Alejandro G.
Gascón i Brustenga, Joaquim
author_role author
author2 Gállego Culleré, M. (Montserrat)
Schijman, Alejandro G.
Gascón i Brustenga, Joaquim
author2_role author
author
author
dc.subject.none.fl_str_mv Genètica molecular
Diagnòstic
Malaltia de Chagas
Molecular genetics
Diagnosis
Chagas' disease
topic Genètica molecular
Diagnòstic
Malaltia de Chagas
Molecular genetics
Diagnosis
Chagas' disease
description Chagas disease is caused by the parasite Trypanosoma cruzi. It affects 7 million people, mainly in Latin America. Diagnosis is usually made serologically, but at some clinical scenarios serology cannot be used. Then, molecular detection is required for early detection of congenital transmission, treatment response follow up, and diagnosis of immune-suppression reactivation. However, present tests are technically demanding and require well-equipped laboratories which make them unfeasible in low-resources endemic regions.
publishDate 2017
dc.date.none.fl_str_mv 2017
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/acceptedVersion
format article
status_str acceptedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/204332
url https://hdl.handle.net/2445/204332
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Versió postprint del document publicat a: https://doi.org/10.1080/14737159.2017.1338566
Expert Review Of Molecular Diagnostics, 2017, vol. 17, num.7, p. 699-710
https://doi.org/10.1080/14737159.2017.1338566
dc.rights.none.fl_str_mv (c) Taylor & Francis, 2017
info:eu-repo/semantics/openAccess
rights_invalid_str_mv (c) Taylor & Francis, 2017
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Taylor & Francis
publisher.none.fl_str_mv Taylor & Francis
dc.source.none.fl_str_mv Articles publicats en revistes (Biologia, Sanitat i Medi Ambient)
reponame:Dipòsit Digital de la UB
instname:Universidad de Barcelona
instname_str Universidad de Barcelona
reponame_str Dipòsit Digital de la UB
collection Dipòsit Digital de la UB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869406511674949632
score 15.198674